Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ribera

Showing results (401-410 of 473) with videos related to

Pageof 48
Sort By:
European Journal of Haematology|May 8, 2013
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual diseaseMontserrat Hoyos, Josep F Nomdedeu, Jordi Esteve, et al.
Actas Dermo-Sifiliograficas|November 29, 2015
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert RecommendationsJ M Carrascosa, P de la Cueva, M Ara, et al.
Medicina Clinica|January 24, 2006
[Prognostic influence of immunological subtypes of T-cell acute lymphoblastic leukemia. Study of 81 patients]Blanca Xicoy, Josep M Ribera, Albert Oriol, et al.
Blood|March 2, 2006
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemiaMariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Haematologica|May 9, 1998
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of HematologyJ M Ribera, J J Ortega, A Oriol, et al.
Leukemia|March 28, 2017
Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemiaC Anadón, G van Tetering, H J Ferreira, et al.
Leukemia|May 27, 2006
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell sourceD Gallardo, A Pérez-García, R de la Cámara, et al.
Actas Dermo-Sifiliograficas|March 13, 2010
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group]M Sánchez-Regaña, E Dilmé, Ll Puig, et al.
European Journal of Clinical Pharmacology|July 3, 2020
Validation of self-reported adherence in chronic patients visiting pharmacies and factors associated with the overestimation and underestimation of good adherenceC Valdés Y Llorca, Ernesto Cortés-Castell, J M Ribera-Casado, et al.
Pageof 48

Showing results (401-410 of 473) with videos related to

Sort By:
Pageof 48
European Journal of Haematology|May 8, 2013
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual diseaseMontserrat Hoyos, Josep F Nomdedeu, Jordi Esteve, et al.
Actas Dermo-Sifiliograficas|November 29, 2015
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert RecommendationsJ M Carrascosa, P de la Cueva, M Ara, et al.
Medicina Clinica|January 24, 2006
[Prognostic influence of immunological subtypes of T-cell acute lymphoblastic leukemia. Study of 81 patients]Blanca Xicoy, Josep M Ribera, Albert Oriol, et al.
Blood|March 2, 2006
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemiaMariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Haematologica|May 9, 1998
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of HematologyJ M Ribera, J J Ortega, A Oriol, et al.
Leukemia|March 28, 2017
Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemiaC Anadón, G van Tetering, H J Ferreira, et al.
Leukemia|May 27, 2006
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell sourceD Gallardo, A Pérez-García, R de la Cámara, et al.
Actas Dermo-Sifiliograficas|March 13, 2010
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group]M Sánchez-Regaña, E Dilmé, Ll Puig, et al.
European Journal of Clinical Pharmacology|July 3, 2020
Validation of self-reported adherence in chronic patients visiting pharmacies and factors associated with the overestimation and underestimation of good adherenceC Valdés Y Llorca, Ernesto Cortés-Castell, J M Ribera-Casado, et al.
Pageof 48